Zaremba Rabourn Amy Insider Trading Activity (IRD)

Summary

Updated Jul 16, 2026

Zaremba Rabourn Amy has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $23K.

Profile

Rabourn Amy Zaremba is identified in the SEC filing context as the Head of Financial Quality Assurance at Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on inherited retinal diseases. The most recent SEC filing dated 2026-01-13 indicates no insider purchases or sales by this individual. Opus Genetics operates a pipeline of AAV-based gene therapies and other retinal therapies with a small team (~18 employees).

Role	Insider
Notability	20/100

Board memberships

Opus Genetics, Inc.

Awards & honors

Listed as Head of Financial Quality Assurance at Opus Genetics in SEC filing

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-04-27	IRD	Opus Genetics, Inc.	S — Open-market sale	1.6K	$5.20	$9K
2026-03-18	IRD	Opus Genetics, Inc.	S — Open-market sale	2.8K	$5.25	$15K
2026-01-27	IRD	Opus Genetics, Inc.	A — Grant or award	86.5K	$0.00
2026-01-21	IRD	Opus Genetics, Inc.	F — Tax withholding / forfeiture	3.4K	$2.10	$7K
2026-01-13	IRD	Opus Genetics, Inc.	F — Tax withholding / forfeiture	4.0K	$1.93	$8K

Frequently Asked Questions

Who is Zaremba Rabourn Amy?

How many SEC Form 4 filings has Zaremba Rabourn Amy submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Zaremba Rabourn Amy been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($23K) across all tracked filings.

Where can I see all of Zaremba Rabourn Amy's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Zaremba Rabourn Amy — SEC Form 4 Insider Trading Activity